These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 830417)

  • 1. Enhancement of mammary tumor formation in mice by a cytostatic drug, melphalan.
    Medina D
    Cancer Res; 1977 Jan; 37(1):317-9. PubMed ID: 830417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormone dependence and estradiol receptors in the D series of mammary nodule outgrowth lines and tumors.
    Medina D; Iramain CA; Clark JH
    Cancer Res; 1975 Sep; 35(9):2355-69. PubMed ID: 167955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A high-tumor-incidence subline of the D1 mouse mammary hyperplastic outgrowth line: effect of carcinogens.
    Ashley RL; Cardiff RD; Pratt TS; Faulkin LJ
    J Natl Cancer Inst; 1982 Sep; 69(3):639-45. PubMed ID: 6287083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of H-ras oncogenes in preneoplastic mouse mammary tissues.
    Kumar R; Medina D; Sukumar S
    Oncogene; 1990 Aug; 5(8):1271-7. PubMed ID: 2118247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nononcogenic hormone-independent alveoli produced by carcinogens in cultured mouse mammary glands.
    Schaefer FV; Tonelli QJ; Dickens MS; Custer RP; Sorof S
    Cancer Res; 1983 Jul; 43(7):3310-5. PubMed ID: 6406057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential expression of preneoplastic and neoplastic characteristics of mouse mammary epithelial cells transformed in organ culture.
    Iyer AP; Banerjee MR
    J Natl Cancer Inst; 1981 May; 66(5):893-905. PubMed ID: 6785507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of mammary tumor virus proteins in preneoplastic outgrowth lines and mammary tumors of BALB/cV mice.
    Slagle BL; Lanford RE; Medina D; Butel JS
    Cancer Res; 1984 May; 44(5):2155-62. PubMed ID: 6324998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of inapparent nodule-transformed cells in the mammary gland tissues of virgin female BALB/cfC3H mice.
    DeOme KB; Miyamoto MJ; Osborn RC; Guzman RC; Lum K
    Cancer Res; 1978 Jul; 38(7):2103-11. PubMed ID: 207423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement and inhibition of mammary tumor formation and growth by cytostatic drugs.
    Medina D; Shepherd F
    Cancer Res; 1977 Oct; 37(10):3571-7. PubMed ID: 908008
    [No Abstract]   [Full Text] [Related]  

  • 10. Microcytotoxicity assay of immune responses to non-mammary tumor virus-induced, preneoplastic, and neoplastic mammary lesions in BALB/c mice.
    Heppner GH; Kopp JS; Medina D
    Cancer Res; 1976 Feb; 36(2 pt 2):753-8. PubMed ID: 1253160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preneoplastic lesions in murine mammary cancer.
    Medina D
    Cancer Res; 1976 Jul; 36(7 PT 2):2589-95. PubMed ID: 179706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphological and functional properties of TM preneoplastic mammary outgrowths.
    Medina D; Kittrell FS; Liu YJ; Schwartz M
    Cancer Res; 1993 Feb; 53(3):663-7. PubMed ID: 7678778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of tumorigenicity with morphological progression in a BALB/c preneoplastic outgrowth line.
    Medina D; Kittrell FS
    J Natl Cancer Inst; 1987 Sep; 79(3):569-76. PubMed ID: 3041094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in p53 are frequent in the preneoplastic stage of mouse mammary tumor development.
    Jerry DJ; Ozbun MA; Kittrell FS; Lane DP; Medina D; Butel JS
    Cancer Res; 1993 Jul; 53(14):3374-81. PubMed ID: 8324748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of pregnancy-specific genes in preneoplastic mouse mammary tissues from virgin mice.
    Smith GH; Vonderhaar BK; Graham DE; Medina D
    Cancer Res; 1984 Aug; 44(8):3426-37. PubMed ID: 6430550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of parity on recovery of inapparent nodule-transformed mammary gland cells in vivo.
    DeOme KB; Miyamoto MJ; Osborn RC; Guzman RC; Lum K
    Cancer Res; 1978 Nov; 38(11 Pt 2):4050-3. PubMed ID: 698953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mammary tumorigenesis in chemical carcinogen-treated mice. VI. Tumor-producing capabilities of mammary dysplasias in BALB/cCrgl mice.
    Medina D
    J Natl Cancer Inst; 1976 Nov; 57(5):1185-9. PubMed ID: 187796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of chemical carcinogen treatment on the immunogenicity of mouse mammary tumors arising from hyperplastic alveolar nodule outgrowth lines.
    Ruppert B; Wei W; Medina D; Heppner GH
    J Natl Cancer Inst; 1978 Oct; 61(4):1165-9. PubMed ID: 100605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of hormone stimulation, dose, and time of administration of carcinogen on carcinogen-induced mammary tumors from preneoplastic nodule outgrowths.
    Medina D
    J Natl Cancer Inst; 1971 Apr; 46(4):909-16. PubMed ID: 5573775
    [No Abstract]   [Full Text] [Related]  

  • 20. Development and characterization of mouse hyperplastic mammary outgrowth lines from BALB/cfC3H hyperplastic alveolar nodules.
    Ashley RL; Cardiff RD; Mitchell DJ; Faulkin LJ; Lund JK
    Cancer Res; 1980 Nov; 40(11):4232-42. PubMed ID: 6258774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.